DHEA-S, Androstenedione, 17- β-estradiol signature as novel biomarkers for early prediction of risk of malignant pleural mesothelioma linked to asbestos-exposure: A preliminary investigation

In conclusion, this study suggests 17-β-estradiol, DHEA-S, and androstenedione as biomarkers for mesothelioma risk and early diagnosis of mesothelioma in asbestos-exposed individuals, aiding timely intervention and improved care.PMID:38692064 | DOI:10.1016/j.biopha.2024.116662

Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - May 1, 2024 Category: Drugs & Pharmacology Authors: Barbara Nuvoli Andrea Sacconi Grazia Bottillo Francesca Sciarra Roberta Libener Antonio Maconi Mariantonia Carosi Giorgio Piperno Eliuccia Mastropasqua Maria Papale Emanuela Camera Rossella Galati Source Type: research